Cargando…
The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
The tissue-selective estrogen complex (TSEC) pairs conjugated estrogens (CE) with a selective estrogen receptor modulator (SERM), bazedoxifene acetate (BZA). A 2-year treatment with the TSEC improved vasomotor symptoms, quality of life, and vaginal atrophy in healthy postmenopausal women. In additio...
Autores principales: | Lello, Stefano, Capozzi, Anna, Scambia, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735652/ https://www.ncbi.nlm.nih.gov/pubmed/29358948 http://dx.doi.org/10.1155/2017/5064725 |
Ejemplares similares
-
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
por: Rossini, Maurizio, et al.
Publicado: (2013) -
Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
por: Komm, Barry S, et al.
Publicado: (2012) -
Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination
por: Mirkin, Sebastian, et al.
Publicado: (2013) -
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
por: Kagan, Risa, et al.
Publicado: (2016) -
Conjugated Estrogens and Bazedoxifene Improve β Cell Function in Obese Menopausal Women
por: Lovre, Dragana, et al.
Publicado: (2019)